S6.B: SPECIFIED STIMULANTS INCLUDING, BUT NOT LIMITED TO: 2-phenylpropan-1-amine (-methylphenylethylamine, BMPEA) 3-Methylhexan-2-amine (1,2-dimethylpentylamine) 4-Fluoromethylphenidate 4-Methylhexan-2-amine (1,3-dimethylamylamine, 1,3 DMAA, methylhexaneamine) 4-Methylpentan-2-amine (1,3-dimethylbutylamine) 5-Methylhexan-2-amine (1,4-dimethylamylamine, 1,4-dimethylpentylamine, 1,4-DMAA) Benzfetamine Cathine** Cathinone and its analogues, e.g
And it promotes blood vessel growth through pathways that don't fully overlap with BPC-157's, which is part of why the two peptides seem to work better together than apart [3]
Through a spokesperson, Vinjamoori declined to identify a specific standard of care
Following those directions sent me back to horrible fatigue & my old symptoms returned
This article examines BPC-157's regulatory status, safety concerns, and established NHS treatments for erectile dysfunction
There was not a significant difference in serious adverse events among patients on brodalumab or placebo
